FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4243920333> ?p ?o ?g. }

• W4243920333 abstract "You have accessJournal of UrologyUrodynamics/Incontinence/Female Urology: Incontinence - Evaluation & Therapy II1 Apr 20101596 EFFECT OF REPEATED INTRADETRUSOR INJECTIONS OF BOTULINUM-A TOXIN ON URODYNAMICS AND CLINICAL PARAMETERS IN PATIENTS WITH REFRACTORY IDIOPATHIC DETRUSOR OVERACTIVITY Daniel Schmid, Sharmistha Roy-Guggenbuehl, Tullio Sulser, and Brigitte Schurch Daniel SchmidDaniel Schmid More articles by this author , Sharmistha Roy-GuggenbuehlSharmistha Roy-Guggenbuehl More articles by this author , Tullio SulserTullio Sulser More articles by this author , and Brigitte SchurchBrigitte Schurch More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2010.02.1374AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Nonneurogenic urinary incontinence is partially due to OAB, which refers to the symptom complex of frequency, urgency and nocturia. OAB is related to a disorder of the storage phase of the bladder. Our former study in 240 pat. shows that a first BoNT-A injection increased maximum cystometric capacity (MCC) and reduced clinical symptoms as urgency, frequency and incontinence. As we lacked knowledge of urodynamic effects of repeated injections, we evaluated in this study urodynamic parameters of consecutive BoNT-A injections in the detrusor muscle in patients with idiopathic OAB resistant to conventional treatment, who needed a second BoNT-A treatment after loss of efficacy of their first injection. METHODS Out of 66 pat. with repeated BoNT-A intradetrusor injections, 45 patients (35 women and 10 men) with relapsing symptoms of OAB underwent clinical checks and standard urodynamic studies before and 12 weeks after their first and second injection, respectively. We compared then the urodynamic parameters measured at baseline and after two consecutive injections of 100 U of BoNT-A. RESULTS The interval between two subsequent treatments reached from min. 4 months to max. 28 months (mean 12 months). We observed a significant increase of the MCC after every consecutive injection, as the MCC increased from a mean baseline of 245 ml to 380 ml after the first injection and to 420 ml after the second injection (p=0.04). The end filling detrusor pressure showed a significant decrease from baseline 41 cmH2O to a mean value of 34 cmH2O (first inj.) and then to 23 cmH2O (second inj.) (p=0.003). Bladder compliance improved from baseline 22 ml/cmH2O to 45 and 52 ml/cmH2O (p=0.0001), respectively. All our patients reported reduced OAB symptoms after treatments, and comparing quality of life, we saw no significant differences between a first and a consecutive injection. CONCLUSIONS Besides the well known efficacy of BoNT-A injections in pat. with refractory idiopathic OAB, we observed in this study a continuous improvement of urodynamic parameters after consecutive treatments; in particular, bladder compliance even increased after a second treatment, banishing some former concern, that repeated injections could negatively affect bladder wall structure. Zurich, Switzerland© 2010 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 183Issue 4SApril 2010Page: e617 Advertisement Copyright & Permissions© 2010 by American Urological Association Education and Research, Inc.MetricsAuthor Information Daniel Schmid More articles by this author Sharmistha Roy-Guggenbuehl More articles by this author Tullio Sulser More articles by this author Brigitte Schurch More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ..." @default.
• W4243920333 created "2022-05-12" @default.
• W4243920333 creator A5028663673 @default.
• W4243920333 creator A5044302538 @default.
• W4243920333 creator A5055617419 @default.
• W4243920333 creator A5080173859 @default.
• W4243920333 date "2010-04-01" @default.
• W4243920333 modified "2023-09-30" @default.
• W4243920333 title "1596 EFFECT OF REPEATED INTRADETRUSOR INJECTIONS OF BOTULINUM-A TOXIN ON URODYNAMICS AND CLINICAL PARAMETERS IN PATIENTS WITH REFRACTORY IDIOPATHIC DETRUSOR OVERACTIVITY" @default.
• W4243920333 doi "https://doi.org/10.1016/j.juro.2010.02.1374" @default.
• W4243920333 hasPublicationYear "2010" @default.
• W4243920333 type Work @default.
• W4243920333 citedByCount "0" @default.
• W4243920333 crossrefType "journal-article" @default.
• W4243920333 hasAuthorship W4243920333A5028663673 @default.
• W4243920333 hasAuthorship W4243920333A5044302538 @default.
• W4243920333 hasAuthorship W4243920333A5055617419 @default.
• W4243920333 hasAuthorship W4243920333A5080173859 @default.
• W4243920333 hasConcept C121332964 @default.
• W4243920333 hasConcept C126322002 @default.
• W4243920333 hasConcept C126894567 @default.
• W4243920333 hasConcept C141071460 @default.
• W4243920333 hasConcept C142424586 @default.
• W4243920333 hasConcept C142724271 @default.
• W4243920333 hasConcept C204787440 @default.
• W4243920333 hasConcept C2777333188 @default.
• W4243920333 hasConcept C2777478456 @default.
• W4243920333 hasConcept C2778531004 @default.
• W4243920333 hasConcept C2778941218 @default.
• W4243920333 hasConcept C2779762690 @default.
• W4243920333 hasConcept C2780616540 @default.
• W4243920333 hasConcept C2781036200 @default.
• W4243920333 hasConcept C71924100 @default.
• W4243920333 hasConcept C77411442 @default.
• W4243920333 hasConcept C87355193 @default.
• W4243920333 hasConceptScore W4243920333C121332964 @default.
• W4243920333 hasConceptScore W4243920333C126322002 @default.
• W4243920333 hasConceptScore W4243920333C126894567 @default.
• W4243920333 hasConceptScore W4243920333C141071460 @default.
• W4243920333 hasConceptScore W4243920333C142424586 @default.
• W4243920333 hasConceptScore W4243920333C142724271 @default.
• W4243920333 hasConceptScore W4243920333C204787440 @default.
• W4243920333 hasConceptScore W4243920333C2777333188 @default.
• W4243920333 hasConceptScore W4243920333C2777478456 @default.
• W4243920333 hasConceptScore W4243920333C2778531004 @default.
• W4243920333 hasConceptScore W4243920333C2778941218 @default.
• W4243920333 hasConceptScore W4243920333C2779762690 @default.
• W4243920333 hasConceptScore W4243920333C2780616540 @default.
• W4243920333 hasConceptScore W4243920333C2781036200 @default.
• W4243920333 hasConceptScore W4243920333C71924100 @default.
• W4243920333 hasConceptScore W4243920333C77411442 @default.
• W4243920333 hasConceptScore W4243920333C87355193 @default.
• W4243920333 hasIssue "4S" @default.
• W4243920333 hasLocation W42439203331 @default.
• W4243920333 hasOpenAccess W4243920333 @default.
• W4243920333 hasPrimaryLocation W42439203331 @default.
• W4243920333 hasRelatedWork W1969146667 @default.
• W4243920333 hasRelatedWork W1980265965 @default.
• W4243920333 hasRelatedWork W2090129632 @default.
• W4243920333 hasRelatedWork W2260653853 @default.
• W4243920333 hasRelatedWork W2334030637 @default.
• W4243920333 hasRelatedWork W2335438033 @default.
• W4243920333 hasRelatedWork W2767918166 @default.
• W4243920333 hasRelatedWork W4242074381 @default.
• W4243920333 hasRelatedWork W4248466144 @default.
• W4243920333 hasRelatedWork W4256631357 @default.
• W4243920333 hasVolume "183" @default.
• W4243920333 isParatext "false" @default.
• W4243920333 isRetracted "false" @default.
• W4243920333 workType "article" @default.